14 Multiple Myeloma Clinical Trials in Commack, NY (2026)

Q: How do I join a clinical trial in Commack?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you.

Recruiting Multiple Myeloma Studies in Commack

NCT05623020Recruiting

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

Elranatamab is a bispecific antibody: binding of elranatamab to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells causes targeted T-cell-mediated cytotoxicity. The main purpose of the ...

Commack, NYPHASE31,116 participantsPfizer

View Study Details

NCT07226609Recruiting

A Dietary Study for People With Multiple Myeloma

The purpose of the study is to find out whether a dietary intervention can affect treatment response and/or quality of life for people with newly diagnosed multiple myeloma receiving standard inductio...

Commack, NYNA220 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06679829Recruiting

A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant

The purpose of this study is to see if siltuximab plus population pharmacokinetic (PK)-dosed melphalan works as well as the usual approach (body surface area \[BSA\]-dosed melphalan) in people with mu...

Commack, NYPHASE2215 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06055894Recruiting

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

The researchers are going this to look at how butyrate levels change in participants' stool after they are on a plant-based diet or dietary supplements (omega-3, curcumin or probiotics) for 2 weeks. A...

Commack, NYNA200 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05640843Recruiting

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gam...

Commack, NYNA180 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06976476Recruiting

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

The main purpose of this study is to see if IgPro20 can prevent infection in people with multiple myeloma (MM) who have hypogammaglobulinemia from receiving bispecific monoclonal antibodies (BsAbs)....

Commack, NYPHASE2100 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06232044Recruiting

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

This phase I/II trial tests the safety, side effects, best dose, and effectiveness of iberdomide in combination with belantamab mafodotin and dexamethasone in treating patients with multiple myeloma (...

Commack, NYPHASE188 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT07099391Recruiting

A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma

The purpose of this study is to find out whether Tec-RVd (teclistamab, lenalidomide, bortezomib, and dexamethasone) after 3 treatment Cycles of Dara-RVd (daratumumab, lenalidomide, bortezomib, and dex...

Commack, NYPHASE165 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05787574Recruiting

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

The researchers are doing this study to find out whether emapalumab or a combination of fludarabine and dexamethasone are effective in preparing people with a primary immune regulatory disorder (PIRD)...

Commack, NYPHASE239 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06873815Recruiting

A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

The researchers are doing this study to see if giving people fluorescein sodium as an IV infusion before their vulvectomy for treating extramammary Paget's disease (EMPD) can help surgeons with perfor...

Commack, NYPHASE227 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07454382Recruiting

A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma

The purpose of this study is to find out whether the combination of elranatamab and cyclophosphamide is an effective treatment for people with relapsed/refractory multiple myeloma (MM) who have risk f...

Commack, NYPHASE226 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06083922Recruiting

A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

The purpose of this study is to find out whether cyclophosphamide, bortezomib, dexamethasone (CyBorD) with daratumumab SC is a safe treatment combination for MGRS-associated kidney disease including c...

Commack, NYPHASE220 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07105059Recruiting

A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

The researchers are doing this study to find out whether combining teclistamab and mezigdomide is a safe and effective treatment approach in people with relapsed/refractory multiple myeloma (MM)....

Commack, NYPHASE118 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06066346Recruiting

A Study of Talquetamab for People with Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

The researchers are doing this study to find out whether talquetamab is an effective treatment after BCMA CAR Tcell therapy for people with relapsed or refractory multiple myeloma. All participants in...

Commack, NYPHASE217 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Multiple Myeloma Clinical Trials in Commack

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 14 multiple myeloma clinical trials recruiting participants in Commack, NY. These studies are seeking a combined 2,331 participants. Research is being sponsored by Pfizer, Memorial Sloan Kettering Cancer Center, Alliance for Clinical Trials in Oncology. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Commack — FAQ

Are there multiple myeloma clinical trials in Commack?

Yes, there are 14 multiple myeloma clinical trials currently recruiting in Commack, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Commack?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you about next steps.

Are clinical trials in Commack free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Commack studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 14 active trials in Commack are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated July 20, 2026 from ClinicalTrials.gov